Skip to content

Clinical trials

Completed Phase 3 Inflammation trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Inflammation Phase: Phase 3 Status: Completed Clear all

114 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20011
20022
20033
20043
20063
20076
20085
20095
201016
20116
20128
20137
20147
20153
20164
20176
20188
20208
20212
20224
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed114

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bausch & Lomb Incorporated10
Amgen5
Sirion Therapeutics, Inc.5
Ache Laboratorios Farmaceuticos S.A.2
Emory University2
Kala Pharmaceuticals, Inc.2
Radboud University Medical Center2
Salvat2
Sun Pharmaceutical Industries Limited2
Xigen SA2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Inflammation114
Pain18
Cataract16
Cardiovascular Diseases6
Psoriasis5
Sepsis5
Arthritis4
Arthritis, Psoriatic4
Atherosclerosis4
Pathologic Processes4

Trials

Showing 1 to 25 of 114. Each trial links to its page on Pharma Observatory.

14 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.